BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Johnson and Johnson
US Army

Generated: December 14, 2017

DrugPatentWatch Database Preview

ROBINUL Drug Profile

« Back to Dashboard

Drug patent expirations by year for ROBINUL

Pharmacology for ROBINUL

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists

Medical Subject Heading (MeSH) Categories for ROBINUL

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Robins AhROBINULglycopyrrolateINJECTABLE;INJECTION014764-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Casper Pharma LlcROBINUL FORTEglycopyrrolateTABLET;ORAL012827-002Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntROBINULglycopyrrolateINJECTABLE;INJECTION017558-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Casper Pharma LlcROBINULglycopyrrolateTABLET;ORAL012827-001Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for ROBINUL

Drugname Dosage Strength RLD Submissiondate
glycopyrrolateTablets1 mgRobinul8/14/2009
glycopyrrolateTablets2 mgRobinul Forte10/12/2010
glycopyrrolateTablets1.5 mgRobinul Forte5/6/2009

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts
Johnson and Johnson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: